{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:56:24Z","timestamp":1793382984304,"version":"4.5.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.mayocp.2022.12.002","type":"journal-article","created":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T08:21:17Z","timestamp":1677831677000},"page":"581-596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Acquired Disorders of Hypomagnesemia"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2598-4782","authenticated-orcid":false,"given":"Mitchell H.","family":"Rosner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nam","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biff F.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Perazella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mayocp.2022.12.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00012.2014","article-title":"Magnesium in man: implications for health and disease","volume":"95","author":"de Baaij","year":"2015","journal-title":"Physiol Rev"},{"issue":"10","key":"10.1016\/j.mayocp.2022.12.002_bib2","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.4239\/wjd.v6.i10.1152","article-title":"Magnesium and type 2 diabetes","volume":"6","author":"Barbagallo","year":"2015","journal-title":"World J Diabetes"},{"issue":"6","key":"10.1016\/j.mayocp.2022.12.002_bib3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3390\/nu10060730","article-title":"The role of magnesium in neurological disorders","volume":"10","author":"Kirkland","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.mayocp.2022.12.002_bib4","author":"National Institutes of Health"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib5","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2174\/1573401313666170427162740","article-title":"Intestinal absorption and factors influencing bioavailability of magnesium\u2013an update","volume":"13","author":"Schuchardt","year":"2017","journal-title":"Curr Nutr Food Sci"},{"issue":"6","key":"10.1016\/j.mayocp.2022.12.002_bib6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3390\/nu10060784","article-title":"TRPM6 is essential for magnesium uptake and epithelial cell function in the colon","volume":"10","author":"Luongo","year":"2018","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1152\/ajplegacy.1974.227.4.891","article-title":"Micropuncture study of magnesium transport along the nephron in the young rat","volume":"227","author":"Brunette","year":"1974","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1016\/j.mayocp.2022.12.002_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF00579944","article-title":"Micropuncture study along the proximal convoluted tubule: electrolyte reabsorption in first convolutions","volume":"354","author":"Le Grimellec","year":"1975","journal-title":"Pflugers Arch"},{"issue":"3","key":"10.1016\/j.mayocp.2022.12.002_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/S0029665121000926","article-title":"Genetic and drug-induced hypomagnesemia: different cause, same mechanism","volume":"80","author":"Bosman","year":"2021","journal-title":"Proc Nutr Soc"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.829","article-title":"An overview of diagnosis and management of drug-induced hypomagnesemia","volume":"9","author":"Liamis","year":"2021","journal-title":"Pharmacol Res Perspect"},{"issue":"2","key":"10.1016\/j.mayocp.2022.12.002_bib11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5414\/CNP68065","article-title":"Proton pump inhibitors and the kidney: critical review","volume":"68","author":"Brewster","year":"2007","journal-title":"Clin Nephrol"},{"issue":"17","key":"10.1016\/j.mayocp.2022.12.002_bib12","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMc066308","article-title":"Proton-pump inhibitors and hypomagnesemic hypoparathyroidism","volume":"355","author":"Epstein","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2022.12.002_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.ajkd.2009.11.019","article-title":"A\u00a0case series of proton pump inhibitor\u2013induced hypomagnesemia","volume":"56","author":"Hoorn","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.mayocp.2022.12.002_bib14","doi-asserted-by":"crossref","unstructured":"Hess MW, Hoenderop JGJ, Bindels RJM, Drenth JPH. Systematic review: hypomagnesaemia induced by proton pump inhibition [published correction appears in Aliment Pharmacol Ther. 2012;36(11-12):1109]. Aliment Pharmacol Ther. 2012;36(5):405\u2013413.","DOI":"10.1111\/j.1365-2036.2012.05201.x"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/ki.2012.462","article-title":"Proton pump inhibitors and hypomagnesemia: a rare but serious complication","volume":"83","author":"Perazella","year":"2013","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.mayocp.2022.12.002_bib16","doi-asserted-by":"crossref","first-page":"152","DOI":"10.5527\/wjn.v5.i2.152","article-title":"Proton-pump inhibitor-induced hypomagnesemia: current research and proposed mechanisms","volume":"5","author":"William","year":"2016","journal-title":"World J Nephrol"},{"issue":"10","key":"10.1016\/j.mayocp.2022.12.002_bib17","doi-asserted-by":"crossref","first-page":"11235","DOI":"10.1096\/fj.201900839R","article-title":"Low gut microbiota diversity and dietary magnesium intake are associated with the development of PPI-induced hypomagnesemia","volume":"33","author":"Gommers","year":"2019","journal-title":"FASEB J"},{"issue":"44","key":"10.1016\/j.mayocp.2022.12.002_bib18","doi-asserted-by":"crossref","first-page":"e17788","DOI":"10.1097\/MD.0000000000017788","article-title":"Proton pump inhibitors and hypomagnesemia: a meta-analysis of observational studies","volume":"98","author":"Srinutta","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.mayocp.2022.12.002_bib19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cgh.2015.10.012","volume":"14","author":"Sharara","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.12.002_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.18388\/abp.2017_1505","article-title":"Short-term proton pump inhibitor treatment may cause hypomagnesemia in critically ill patients: a pilot study","volume":"64","author":"Krzych \u0141J","year":"2017","journal-title":"Acta Biochim Pol"},{"issue":"5","key":"10.1016\/j.mayocp.2022.12.002_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197400","article-title":"Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease","volume":"13","author":"Hughes","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.mayocp.2022.12.002_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejim.2016.01.026","article-title":"Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis?","volume":"30","author":"Mikolasevic","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"7","key":"10.1016\/j.mayocp.2022.12.002_bib23","first-page":"837.e1-e2","article-title":"Paradoxical hypomagnesemia caused by excessive ingestion of magnesium hydroxide","volume":"26","author":"Suk","year":"2008","journal-title":"Am J Emerg Med"},{"issue":"10","key":"10.1016\/j.mayocp.2022.12.002_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/01.JAA.0000524721.01579.c9","article-title":"Antibiotic-associated diarrhea","volume":"30","author":"Giannelli","year":"2017","journal-title":"JAAPA"},{"issue":"1","key":"10.1016\/j.mayocp.2022.12.002_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1758834009355164","article-title":"Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management","volume":"2","author":"Stein","year":"2010","journal-title":"Ther Adv Med Oncol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/phar.1906","article-title":"Systematic review and meta-analysis of patiromer and sodium zirconium cyclosilicate: a new armamentarium for the treatment of hyperkalemia","volume":"37","author":"Meaney","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.mayocp.2022.12.002_bib27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00280-017-3392-8","article-title":"Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management","volume":"80","author":"Oronsky","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"issue":"12","key":"10.1016\/j.mayocp.2022.12.002_bib28","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s00467-018-3976-5","article-title":"Long-term renal follow-up of children treated with cisplatin, carboplatin, or ifosfamide: a pilot study","volume":"33","author":"McMahon","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.12.002_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/ctrv.1999.0097","article-title":"Cisplatin and hypomagnesemia","volume":"25","author":"Lajer","year":"1999","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"10.1016\/j.mayocp.2022.12.002_bib30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/01926230490508821","article-title":"Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology","volume":"32","author":"Vickers","year":"2004","journal-title":"Toxicol Pathol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib31","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/ndt\/gfs499","article-title":"Cisplatin-induced injury of the renal distal convoluted tubule is associated with hypomagnesaemia in mice","volume":"28","author":"van Angelen","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.mayocp.2022.12.002_bib32","first-page":"1767","article-title":"Persistent hypomagnesemia following cisplatin chemotherapy for testicular cancer","volume":"66","author":"Schilsky","year":"1982","journal-title":"Cancer Treat Rep"},{"issue":"1","key":"10.1016\/j.mayocp.2022.12.002_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/(SICI)1096-911X(199701)28:1<35::AID-MPO7>3.0.CO;2-U","article-title":"Acute and chronic effects of cisplatin therapy on renal magnesium homeostasis","volume":"28","author":"Ariceta","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.mayocp.2022.12.002_bib34","doi-asserted-by":"crossref","unstructured":"St\u00f6hr W, Paulides M, Bielack S, et\u00a0al. Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: a report from the Late Effects Surveillance System. Pediatr Blood Cancer. 2007;48(2):140\u2013147.","DOI":"10.1002\/pbc.20812"},{"key":"10.1016\/j.mayocp.2022.12.002_bib35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2369-7-10","article-title":"Gitelman-like syndrome after cisplatin therapy: a case report and literature review","volume":"7","author":"Panichpisal","year":"2006","journal-title":"BMC Nephrol"},{"issue":"8","key":"10.1016\/j.mayocp.2022.12.002_bib36","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0149-2918(04)80177-2","article-title":"Cisplatin-induced hypokalemic paralysis","volume":"26","author":"Mohammadianpanah","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.mayocp.2022.12.002_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejphar.2017.05.034","article-title":"Magnesium attenuates cisplatin-induced nephrotoxicity by regulating the expression of renal transporters","volume":"811","author":"Saito","year":"2017","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.12.002_bib38","first-page":"e117","article-title":"Management of epidermal growth factor receptor inhibitor-induced hypomagnesemia: a systematic review","volume":"15","author":"Jiang","year":"2016","journal-title":"Clin Colorectal Cancer"},{"issue":"5","key":"10.1016\/j.mayocp.2022.12.002_bib39","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1007\/s13277-014-2983-9","article-title":"Electrolyte disorders assessment in solid tumor patients treated with anti-EGFR monoclonal antibodies: a pooled analysis of 25 randomized clinical trials","volume":"36","author":"Wang","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.mayocp.2022.12.002_bib40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2016.02.064","article-title":"Electrolyte disorders associated with the use of anticancer drugs","volume":"777","author":"Liamis","year":"2016","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.mayocp.2022.12.002_bib41","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00280-014-2459-z","article-title":"An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck","volume":"73","author":"Saloura","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"10.1016\/j.mayocp.2022.12.002_bib42","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1172\/JCI31680","article-title":"Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia","volume":"117","author":"Groenestege","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.mayocp.2022.12.002_bib43","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fonc.2016.00196","article-title":"Incidence and risk factors of hypomagnesemia in head and neck cancer patients treated with cetuximab","volume":"6","author":"Enokida","year":"2016","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.12.002_bib44","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00280-018-3758-6","article-title":"Increase in cetuximab-induced skin rash and hypomagnesemia in patients receiving concomitant treatment with proton pump inhibitors (PPIs): a possible drug interaction?","volume":"83","author":"Abu-Amna","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"issue":"16","key":"10.1016\/j.mayocp.2022.12.002_bib45","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/dji242","article-title":"Cetuximab therapy and symptomatic hypomagnesemia","volume":"97","author":"Schrag","year":"2005","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.mayocp.2022.12.002_bib46","doi-asserted-by":"crossref","unstructured":"Osorio JM, Bravo J, P\u00e9rez A, Ferreyra C, Osuna A. Magnesemia in renal transplant recipients: relation with immunosuppression and posttransplant diabetes. Transplant Proc. 2010;42(8):2910\u20132913.","DOI":"10.1016\/j.transproceed.2010.08.016"},{"issue":"1","key":"10.1016\/j.mayocp.2022.12.002_bib47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/17843286.2018.1549193","article-title":"Electrolytes disturbances after kidney transplantation","volume":"74","author":"De Waele","year":"2019","journal-title":"Acta Clin Belg"},{"issue":"8","key":"10.1016\/j.mayocp.2022.12.002_bib48","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/01.TP.0000174340.40585.D4","article-title":"Effects of immunosuppressive agents on magnesium metabolism early after allogeneic hematopoietic stem cell transplantation","volume":"80","author":"Aisa","year":"2005","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib49","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.transproceed.2017.01.070","article-title":"Serum magnesium and related factors in long-term renal transplant recipients: an observational study","volume":"49","author":"Rodrigues","year":"2017","journal-title":"Transplant Proc"},{"issue":"7","key":"10.1016\/j.mayocp.2022.12.002_bib50","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3109\/0886022X.2014.917561","article-title":"Magnesium excretion and hypomagnesemia in pediatric renal transplant recipients","volume":"36","author":"Uslu G\u00f6kceo\u011flu","year":"2014","journal-title":"Ren Fail"},{"issue":"5","key":"10.1016\/j.mayocp.2022.12.002_bib51","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000522233","article-title":"Impact of post-transplantation hypomagnesemia on long-term graft and patient survival after transplantation","volume":"47","author":"Isakov","year":"2022","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"10.1016\/j.mayocp.2022.12.002_bib52","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/oxfordjournals.ndt.a092115","article-title":"Thomas TH, Harrison K, Wilkinson R. Reduced erythrocyte and leukocyte magnesium is associated with cyclosporin treatment and hypertension in renal transplant patients","volume":"7","author":"al-Khursany I","year":"1992","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.mayocp.2022.12.002_bib53","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00007890-200202150-00005","article-title":"Role of hypomagnesemia in chronic cyclosporine nephropathy","volume":"73","author":"Miura","year":"2002","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.mayocp.2022.12.002_bib54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/1526924816633949","article-title":"New-onset diabetes after kidney transplantation and pretransplant hypomagnesemia","volume":"26","author":"Sinangil","year":"2016","journal-title":"Prog Transplant"},{"issue":"11","key":"10.1016\/j.mayocp.2022.12.002_bib55","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/lt.22146","article-title":"Hypomagnesemia and the risk of new-onset diabetes after liver transplantation","volume":"16","author":"Van Laecke","year":"2010","journal-title":"Liver Transpl"},{"issue":"5","key":"10.1016\/j.mayocp.2022.12.002_bib56","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ndt\/gft498","article-title":"Magnesium loss in cyclosporine-treated patients is related to renal epidermal growth factor downregulation","volume":"29","author":"Ledeganck","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib57","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0887-8994(00)00198-3","article-title":"Cyclosporine A neurotoxicity in a patient with idiopathic renal magnesium wasting","volume":"23","author":"Al-Rasheed","year":"2000","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.mayocp.2022.12.002_bib58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/IJNRD.S42054","article-title":"Hypomagnesemia: a clinical perspective","volume":"7","author":"Pham","year":"2014","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"6","key":"10.1016\/j.mayocp.2022.12.002_bib59","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.bbamem.2010.11.006","article-title":"Decrease in transient receptor potential melastatin 6 mRNA stability caused by rapamycin in renal tubular epithelial cells","volume":"1808","author":"Ikari","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.mayocp.2022.12.002_bib60","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.transproceed.2010.07.081","article-title":"Valero San Cecilio R, Calvo Romero N, Vilalta Casas R. Changes in magnesium and potassium homeostasis after conversion from a calcineurin inhibitor regimen to an mTOR inhibitor-based regimen","volume":"42","author":"S\u00e1nchez-Fructuoso","year":"2010","journal-title":"Transplant Proc"},{"issue":"9","key":"10.1016\/j.mayocp.2022.12.002_bib61","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2165\/00002018-200528090-00003","article-title":"Drug-induced hypomagnesaemia: scope and management","volume":"28","author":"Atsmon","year":"2005","journal-title":"Drug Saf"},{"issue":"11","key":"10.1016\/j.mayocp.2022.12.002_bib62","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/pds.4636","article-title":"Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population","volume":"27","author":"Kieboom","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"10.1016\/j.mayocp.2022.12.002_bib63","doi-asserted-by":"crossref","first-page":"107402","DOI":"10.1016\/j.jdiacomp.2019.06.007","article-title":"Correction of hypomagnesemia by dapagliflozin in patients with type 2 diabetes: a post hoc analysis of 10 randomized, placebo-controlled trials","volume":"33","author":"Toto","year":"2019","journal-title":"J\u00a0Diabetes Complications"},{"issue":"3","key":"10.1016\/j.mayocp.2022.12.002_bib64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.xkme.2020.01.010","article-title":"SGLT2 inhibitors for treatment of refractory hypomagnesemia: a case report of 3 patients","volume":"2","author":"Ray","year":"2020","journal-title":"Kidney Med"},{"issue":"9","key":"10.1016\/j.mayocp.2022.12.002_bib65","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/nep.13552","article-title":"Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: a comparison study with furosemide and tolvaptan","volume":"24","author":"Ohara","year":"2019","journal-title":"Nephrology (Carlton)"},{"issue":"6","key":"10.1016\/j.mayocp.2022.12.002_bib66","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s004670050378","article-title":"Gentamicin-induced Bartter-like syndrome","volume":"11","author":"Landau","year":"1997","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.12.002_bib67","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00043426-199602000-00017","article-title":"Hypermagnesiuria and hypercalciuria in childhood leukemia: an effect of amikacin therapy","volume":"18","author":"Wu","year":"1996","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.12.002_bib68","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1067\/mcp.2000.103864","article-title":"Gentamicin effects on urinary electrolyte excretion in healthy subjects","volume":"67","author":"Elliott","year":"2000","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.mayocp.2022.12.002_bib69","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4103\/0971-4065.177206","article-title":"Acquired Bartter syndrome following gentamicin therapy","volume":"26","author":"Singh","year":"2016","journal-title":"Indian J Nephrol"},{"issue":"6","key":"10.1016\/j.mayocp.2022.12.002_bib70","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/sj.ki.5001654","article-title":"Dysregulation of renal sodium transporters in gentamicin-treated rats","volume":"70","author":"Sassen","year":"2006","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.mayocp.2022.12.002_bib71","first-page":"463","article-title":"Amphotericin B-induced nephrotoxicity: a review","volume":"12","author":"Fanos","year":"2000","journal-title":"J\u00a0Chemother"},{"issue":"5","key":"10.1016\/j.mayocp.2022.12.002_bib72","first-page":"278","article-title":"Comparison of adverse events and hospital length of stay associated with various amphotericin B formulations: sequential conventional amphotericin b\/lipid versus lipid-only therapy for the treatment of invasive fungal infections in hospitalized patients","volume":"38","author":"Wade","year":"2013","journal-title":"P\u00a0T"},{"issue":"24","key":"10.1016\/j.mayocp.2022.12.002_bib73","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1056\/NEJMoa1613306","article-title":"A\u00a0trial of itraconazole or amphotericin B for HIV-associated talaromycosis","volume":"376","author":"Le","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mayocp.2022.12.002_bib74","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0002-9343(84)90106-2","article-title":"Renal magnesium wasting associated with amphotericin B therapy","volume":"77","author":"Barton","year":"1984","journal-title":"Am J Med"},{"issue":"pt 2","key":"10.1016\/j.mayocp.2022.12.002_bib75","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0004563213517628","article-title":"Contemporary view of the clinical relevance of magnesium homeostasis","volume":"51","author":"Ayuk","year":"2014","journal-title":"Ann Clin Biochem"},{"issue":"11-12","key":"10.1016\/j.mayocp.2022.12.002_bib76","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1515\/CCLM.1999.151","article-title":"Magnesium in disease: a review with special emphasis on the serum ionized magnesium","volume":"37","author":"Sanders","year":"1999","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib77","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/07315724.1986.10720143","article-title":"Serum magnesium levels in the United States, 1971-1974","volume":"5","author":"Lowenstein","year":"1986","journal-title":"J\u00a0Am Coll Nutr"},{"issue":"6","key":"10.1016\/j.mayocp.2022.12.002_bib78","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3945\/an.116.012765","article-title":"Perspective: the case for an evidence-based reference interval for serum magnesium: the time has come","volume":"7","author":"Costello","year":"2016","journal-title":"Adv Nutr"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib79","first-page":"271","article-title":"Correlation between bone magnesium concentration and magnesium retention in the intravenous magnesium load test","volume":"3","author":"Cohen","year":"1990","journal-title":"Magnes Res"},{"issue":"5","key":"10.1016\/j.mayocp.2022.12.002_bib80","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/07315724.2019.1691953","article-title":"An 8-year analysis of magnesium status in elite international track & field athletes","volume":"39","author":"Pollock","year":"2020","journal-title":"J\u00a0Am Coll Nutr"},{"issue":"1","key":"10.1016\/j.mayocp.2022.12.002_bib81","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/07315724.1987.10720163","article-title":"Changes in serum magnesium concentration after strenuous exercise (published correction appears in J Am Coll Nutr. 1988;7(1):following 88]","volume":"6","author":"Stendig-Lindberg","year":"1987","journal-title":"J\u00a0Am Coll Nutr"},{"issue":"2","key":"10.1016\/j.mayocp.2022.12.002_bib82","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/sj.ejcn.1602062","article-title":"Long-term effect of a plant-based diet on magnesium status during pregnancy","volume":"59","author":"Koebnick","year":"2005","journal-title":"Eur J Clin Nutr"},{"issue":"1","key":"10.1016\/j.mayocp.2022.12.002_bib83","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0009-8981(78)90054-2","article-title":"Serum magnesium circadian rhythm in human adults with respect to age, sex and mental status","volume":"87","author":"Touitou","year":"1978","journal-title":"Clin Chim Acta"},{"issue":"pt 6","key":"10.1016\/j.mayocp.2022.12.002_bib84","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1258\/acb.2008.007241","article-title":"Spurious hyperkalaemia due to EDTA contamination: common and not always easy to identify","volume":"45","author":"Cornes","year":"2008","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib85","first-page":"635","article-title":"An experimental study of magnesium deficiency in man","volume":"15","author":"Fitzgerald","year":"1956","journal-title":"Clin Sci"},{"key":"10.1016\/j.mayocp.2022.12.002_bib86","first-page":"1","article-title":"Magnesium deficiency in gastrointestinal fluid loss","author":"Thoren","year":"1963","journal-title":"Acta Chir Scand Suppl"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib87","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/00365519209088355","article-title":"Magnesium deficiency diagnosed by an intravenous loading test","volume":"52","author":"Gullestad","year":"1992","journal-title":"Scand J Clin Lab Invest"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib88","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2796.1999.00580.x","article-title":"Can one really measure magnesium deficiency using the short-term magnesium loading test?","volume":"246","author":"Rob","year":"1999","journal-title":"J\u00a0Intern Med"},{"issue":"14","key":"10.1016\/j.mayocp.2022.12.002_bib89","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMra1704724","article-title":"Electrolyte disturbances in patients with chronic alcohol-use disorder","volume":"377","author":"Palmer","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mayocp.2022.12.002_bib90","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000501121","article-title":"Subcutaneous magnesium sulfate to correct high-output ileostomy-induced hypomagnesemia","volume":"13","author":"Makowsky","year":"2019","journal-title":"Case Rep Gastroenterol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib91","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2125.1993.tb04153.x","article-title":"A\u00a0comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects","volume":"35","author":"Murdoch","year":"1993","journal-title":"Br J Clin Pharmacol"},{"issue":"2, pt 2","key":"10.1016\/j.mayocp.2022.12.002_bib92","first-page":"F249","article-title":"Mechanisms of amiloride stimulation of Mg2+ uptake in immortalized mouse distal convoluted tubule cells","volume":"272","author":"Dai","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.mayocp.2022.12.002_bib93","doi-asserted-by":"crossref","unstructured":"Tang H, Zhang X, Zhang J, et\u00a0al. Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials. Diabetologia. 2016;59(12):2546\u20132551.","DOI":"10.1007\/s00125-016-4101-6"},{"issue":"2","key":"10.1016\/j.mayocp.2022.12.002_bib94","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s13300-017-0232-0","article-title":"Effects of canagliflozin on serum magnesium in patients with type 2 diabetes mellitus: a post hoc analysis of randomized controlled trials","volume":"8","author":"Gilbert","year":"2017","journal-title":"Diabetes Ther"},{"issue":"3","key":"10.1016\/j.mayocp.2022.12.002_bib95","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/03007995.2016.1271779","article-title":"Diabetes and kidney disease: the role of sodium-glucose cotransporter-2 (SGLT-2) and SGLT-2 inhibitors in modifying disease outcomes","volume":"33","author":"Mende","year":"2017","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"10.1016\/j.mayocp.2022.12.002_bib96","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.2215\/CJN.17621120","article-title":"Euglycemic ketoacidosis as a complication of SGLT2 inhibitor therapy","volume":"16","author":"Palmer","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib97","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00581632","article-title":"Effect of glucagon on magnesium renal reabsorption in the rat","volume":"392","author":"Bailly","year":"1982","journal-title":"Pflugers Arch"},{"issue":"5","key":"10.1016\/j.mayocp.2022.12.002_bib98","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ki.1997.443","article-title":"Renal magnesium handling: new insights in understanding old problems","volume":"52","author":"Quamme","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/j.mayocp.2022.12.002_bib99","doi-asserted-by":"crossref","unstructured":"Ferrannini E, Muscelli E, Frascerra S, et\u00a0al. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients [published correction appears in J Clin Invest. 2014;124(4):1868]. J Clin Invest. 2014;124(2):499\u2013508.","DOI":"10.1172\/JCI72227"},{"issue":"12","key":"10.1016\/j.mayocp.2022.12.002_bib100","doi-asserted-by":"crossref","first-page":"F1386","DOI":"10.1152\/ajprenal.00593.2013","article-title":"Downregulation of transient receptor potential M6 channels as a cause of hypermagnesiuric hypomagnesemia in obese type 2 diabetic rats","volume":"308","author":"Takayanagi","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"10.1016\/j.mayocp.2022.12.002_bib101","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.3390\/nu13114088","article-title":"Effect of dapagliflozin and magnesium supplementation on renal magnesium handling and magnesium homeostasis in metabolic syndrome","volume":"13","author":"Ng","year":"2021","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.mayocp.2022.12.002_bib102","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1185\/03007995.2014.919907","article-title":"Effect of canagliflozin on serum electrolytes in patients with type 2 diabetes in relation to estimated glomerular filtration rate (eGFR)","volume":"30","author":"Weir","year":"2014","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"10.1016\/j.mayocp.2022.12.002_bib103","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S2213-8587(14)70227-X","article-title":"Possible adverse effects of SGLT2 inhibitors on bone","volume":"3","author":"Taylor","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.mayocp.2022.12.002_bib104","doi-asserted-by":"crossref","first-page":"e99123","DOI":"10.1172\/jci.insight.99123","article-title":"Canagliflozin triggers the FGF23\/1,25-dihydroxyvitamin D\/PTH axis in healthy volunteers in a randomized crossover study","volume":"3","author":"Blau","year":"2018","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MNH.0000000000000505","article-title":"Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus","volume":"28","author":"Vinke","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib106","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1172\/JCI110514","article-title":"Magnesium transport in the cortical thick ascending limb of Henle's loop of the rabbit","volume":"69","author":"Shareghi","year":"1982","journal-title":"J\u00a0Clin Invest"},{"issue":"16","key":"10.1016\/j.mayocp.2022.12.002_bib107","doi-asserted-by":"crossref","first-page":"E3344","DOI":"10.1073\/pnas.1616733114","article-title":"Parathyroid hormone controls paracellular Ca2 transport in the thick ascending limb by regulating the tight-junction protein Claudin14","volume":"114","author":"Sato","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.mayocp.2022.12.002_bib108","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1038\/emboj.2012.49","article-title":"Claudin-14 regulates renal Ca++ transport in response to CaSR signalling via a novel microRNA pathway","volume":"31","author":"Gong","year":"2012","journal-title":"EMBO J"},{"issue":"9","key":"10.1016\/j.mayocp.2022.12.002_bib109","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1681\/ASN.2021010042","article-title":"Molecular mechanisms of renal magnesium reabsorption","volume":"32","author":"Ellison","year":"2021","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.mayocp.2022.12.002_bib110","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1096\/fj.201802094R","article-title":"Tubular flow activates magnesium transport in the distal convoluted tubule","volume":"33","author":"Verschuren","year":"2019","journal-title":"FASEB J"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622006954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622006954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:40:24Z","timestamp":1758418824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619622006954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0025619622006954"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.12.002","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acquired Disorders of Hypomagnesemia","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}